183 related articles for article (PubMed ID: 24816798)
41. [Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung].
Xu XY; Zhi C; Li YM; Qi WJ; Mei JJ; Yan ZM; Shen H
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):151-5. PubMed ID: 22800476
[TBL] [Abstract][Full Text] [Related]
42. The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis.
Chen Y; Huang Y; Huang Y; Chen J; Wang S; Zhou J
PLoS One; 2013; 8(8):e71140. PubMed ID: 23990933
[TBL] [Abstract][Full Text] [Related]
43. The association of melanoma-associated antigen-A gene expression with clinicopathological characteristics and prognosis in resected non-small-cell lung cancer: a meta-analysis.
Wang Y; Lu Y; Li J; Wu Y; Che G
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):855-860. PubMed ID: 31384932
[TBL] [Abstract][Full Text] [Related]
44. Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: an observational cohort study.
Guo X; Li M; Wang X; Pan Y; Li J
BMC Pulm Med; 2021 Apr; 21(1):111. PubMed ID: 33794845
[TBL] [Abstract][Full Text] [Related]
45. Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Sun Y; Li D; Lv XH; Hua SC; Han JC; Xu F; Li XD
J Res Med Sci; 2015 Dec; 20(12):1138-46. PubMed ID: 26958047
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
[TBL] [Abstract][Full Text] [Related]
48. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
Zhang X; Dang Y; Li P; Rong M; Chen G
Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
50. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
Zhang Y; Ma M; Han B
Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis.
Zou XL; Wang C; Liu KE; Nie W; Ding ZY
Mol Clin Oncol; 2015 May; 3(3):633-638. PubMed ID: 26137280
[TBL] [Abstract][Full Text] [Related]
52. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
[TBL] [Abstract][Full Text] [Related]
53. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
54. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
55. Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer.
Schneider S; Yochim J; Brabender J; Uchida K; Danenberg KD; Metzger R; Schneider PM; Salonga D; Hölscher AH; Danenberg PV
Clin Cancer Res; 2004 Mar; 10(5):1588-96. PubMed ID: 15014008
[TBL] [Abstract][Full Text] [Related]
56. Deletion of osteopontin in non-small cell lung cancer cells affects bone metabolism by regulating miR-34c/Notch1 axis: a clue to bone metastasis.
Guo J; Tong CY; Shi JG; Li XJ; Chen XQ
Eur J Histochem; 2023 Jul; 67(3):. PubMed ID: 37491944
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer.
Jin S; Zhu W; Shi Q; Zhang Z; Guo R
Med Oncol; 2012 Dec; 29(5):3157-61. PubMed ID: 22528515
[TBL] [Abstract][Full Text] [Related]
58. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
59. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance.
Fan C; Zhao Y; Liu D; Zhang X; Wang E
Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980
[TBL] [Abstract][Full Text] [Related]
60. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]